# LAZANDA
> **NDA022569** · New Drug Application · Sponsor: BTCP PHARMA · Approved 2011-06-30
## Drug
- **FDA Application Number:** NDA022569
- **Application type:** New Drug Application
- **Brand name:** LAZANDA
- **Generic name:** Fentanyl Citrate
- **Active ingredients:** FENTANYL CITRATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Discontinued
- **Sponsor:** BTCP PHARMA
- **First approval:** 2011-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022569)
---
*AI Analytics · CC0 1.0*